title: Evidence-based guidelines for the management of Lyme disease.
abstract: This report, completed in November 2003, is intended to serve as a resource for physicians, public health officials and organizations involved in the evaluation and treatment of Lyme disease.
authors.affiliation: ILADS, P.O. Box 341461, Bethesda, MD 20827-1461, USA.
authors.forename: Daniel
authors.initials: D
authors.lastname: Cameron
authors.forename: Andrea
authors.initials: A
authors.lastname: Gaito
authors.forename: Nick
authors.initials: N
authors.lastname: Harris
authors.forename: Gregory
authors.initials: G
authors.lastname: Bach
authors.forename: Sabra
authors.initials: S
authors.lastname: Bellovin
authors.forename: Kenneth
authors.initials: K
authors.lastname: Bock
authors.forename: Steven
authors.initials: S
authors.lastname: Bock
authors.forename: Joseph
authors.initials: J
authors.lastname: Burrascano
authors.forename: Constance
authors.initials: C
authors.lastname: Dickey
authors.forename: Richard
authors.initials: R
authors.lastname: Horowitz
authors.forename: Steven
authors.initials: S
authors.lastname: Phillips
authors.forename: Laurence
authors.initials: L
authors.lastname: Meer-Scherrer
authors.forename: Bernard
authors.initials: B
authors.lastname: Raxlen
authors.forename: Virginia
authors.initials: V
authors.lastname: Sherr
authors.forename: Harold
authors.initials: H
authors.lastname: Smith
authors.forename: Pat
authors.initials: P
authors.lastname: Smith
authors.forename: Raphael
authors.initials: R
authors.lastname: Stricker
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D006801:Humans; D008193:Lyme Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000900:Anti-Bacterial Agents